Treatment of urge incontinence in Veterans Affairs medical centers

Daniel C Malone, Gary J. Okano

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8%), dicyclomine hydrochloride (16.0%), or imipramine hydrochloride (13.9%), and the remaining 30.3% were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1% of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3%) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6% of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4% to 20.8%; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.

Original languageEnglish (US)
Pages (from-to)867-877
Number of pages11
JournalClinical Therapeutics
Volume21
Issue number5
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Urge Urinary Incontinence
Veterans
Dicyclomine
Urinary Incontinence
Therapeutics
Imipramine
Adult Diapers
Flavoxate
Chronic Disease
Propantheline
Hyoscyamine
Overactive Urinary Bladder
Prescription Drugs
Pharmaceutical Preparations
Population
Prescriptions
Economics
Databases
Psychology

Keywords

  • Department of Veterans Affairs medical center
  • Dicyclomine
  • Imipramine
  • Oxybutynin
  • Urge incontinence

ASJC Scopus subject areas

  • Pharmacology

Cite this

Treatment of urge incontinence in Veterans Affairs medical centers. / Malone, Daniel C; Okano, Gary J.

In: Clinical Therapeutics, Vol. 21, No. 5, 1999, p. 867-877.

Research output: Contribution to journalArticle

@article{2ea499e1374d4dd1843d1978657224f9,
title = "Treatment of urge incontinence in Veterans Affairs medical centers",
abstract = "Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8{\%}), dicyclomine hydrochloride (16.0{\%}), or imipramine hydrochloride (13.9{\%}), and the remaining 30.3{\%} were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1{\%} of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3{\%}) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6{\%} of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4{\%} to 20.8{\%}; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.",
keywords = "Department of Veterans Affairs medical center, Dicyclomine, Imipramine, Oxybutynin, Urge incontinence",
author = "Malone, {Daniel C} and Okano, {Gary J.}",
year = "1999",
doi = "10.1016/S0149-2918(99)80008-3",
language = "English (US)",
volume = "21",
pages = "867--877",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "5",

}

TY - JOUR

T1 - Treatment of urge incontinence in Veterans Affairs medical centers

AU - Malone, Daniel C

AU - Okano, Gary J.

PY - 1999

Y1 - 1999

N2 - Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8%), dicyclomine hydrochloride (16.0%), or imipramine hydrochloride (13.9%), and the remaining 30.3% were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1% of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3%) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6% of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4% to 20.8%; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.

AB - Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8%), dicyclomine hydrochloride (16.0%), or imipramine hydrochloride (13.9%), and the remaining 30.3% were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1% of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3%) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6% of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4% to 20.8%; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.

KW - Department of Veterans Affairs medical center

KW - Dicyclomine

KW - Imipramine

KW - Oxybutynin

KW - Urge incontinence

UR - http://www.scopus.com/inward/record.url?scp=0033005421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033005421&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(99)80008-3

DO - 10.1016/S0149-2918(99)80008-3

M3 - Article

C2 - 10397381

AN - SCOPUS:0033005421

VL - 21

SP - 867

EP - 877

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 5

ER -